ANDA 40185, held by Pharmobedient. Prochlorperazine Maleate.
As of Nov 16, 2026, ANDA 40185 (Prochlorperazine Maleate), held by Pharmobedient, was first approved by FDA on Oct 28, 1996, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 1996 | Original application | Approved | None posted |
| Prochlorperazine MaleateEQ 10MG BASE · tablet;oral | Prochlorperazine Maleate | Discontinued |
| Prochlorperazine MaleateEQ 5MG BASE · tablet;oral | Prochlorperazine Maleate | Discontinued |
| Jan 22, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 3, 2010 | Supplement 12Labeling | Approved | None posted |
| Jul 22, 2009 | Supplement 11Labeling | Approved | None posted |
| Nov 19, 2008 | Supplement 9Labeling | Approved | None posted |
| May 29, 2008 | Supplement 8Labeling | Approved | None posted |
| Jun 22, 2006 | Supplement 5Labeling | Approved | None posted |
| Dec 13, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Dec 9, 2002 | Supplement 2Labeling | Approved | None posted |
| Feb 5, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Oct 28, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters